Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122769284 | 12276928 | 4 | F | 20160404 | 20160811 | 20160418 | 20160816 | EXP | US-GLAXOSMITHKLINE-US2016GSK046073 | GLAXOSMITHKLINE | 72.62 | YR | M | Y | 0.00000 | 20160816 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122769284 | 12276928 | 1 | PS | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | UNK | U | LU2Y | 20983 | |||||||||
122769284 | 12276928 | 2 | SS | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | Respiratory (inhalation) | 2 PUFF(S), PRN | U | 6ZP3853 | 20983 | 2 | DF | ||||||
122769284 | 12276928 | 3 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | U | 0 | |||||||||||
122769284 | 12276928 | 4 | SS | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | U | 0 | |||||||||||
122769284 | 12276928 | 5 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | U | 0 | |||||||||||
122769284 | 12276928 | 6 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | U | 0 | |||||||||||
122769284 | 12276928 | 7 | C | ELIQUIS | APIXABAN | 1 | U | 0 | |||||||||||
122769284 | 12276928 | 8 | C | COREG | CARVEDILOL | 1 | U | 0 | |||||||||||
122769284 | 12276928 | 9 | C | FLUOXETINE | FLUOXETINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
122769284 | 12276928 | 10 | C | ISOSORBIDE. | ISOSORBIDE | 1 | U | 0 | |||||||||||
122769284 | 12276928 | 11 | C | FUROSEMIDE. | FUROSEMIDE | 1 | U | 0 | |||||||||||
122769284 | 12276928 | 12 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | U | 0 | |||||||||||
122769284 | 12276928 | 13 | C | ASPIRIN (BABY) | ASPIRIN | 1 | U | 0 | |||||||||||
122769284 | 12276928 | 14 | C | LISINOPRIL. | LISINOPRIL | 1 | U | 0 | |||||||||||
122769284 | 12276928 | 15 | C | MAGNESIUM | MAGNESIUM | 1 | U | 0 | |||||||||||
122769284 | 12276928 | 16 | C | OXYCODONE | OXYCODONE | 1 | U | 0 | |||||||||||
122769284 | 12276928 | 17 | C | NITROSTAT | NITROGLYCERIN | 1 | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
122769284 | 12276928 | 1 | Product used for unknown indication |
122769284 | 12276928 | 3 | Product used for unknown indication |
122769284 | 12276928 | 4 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
122769284 | 12276928 | HO |
122769284 | 12276928 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
122769284 | 12276928 | Blood electrolytes decreased | |
122769284 | 12276928 | Blood magnesium decreased | |
122769284 | 12276928 | Blood potassium decreased | |
122769284 | 12276928 | Hypoacusis | |
122769284 | 12276928 | Malaise | |
122769284 | 12276928 | Myocardial infarction | |
122769284 | 12276928 | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
122769284 | 12276928 | 1 | 20160102 | 0 | ||
122769284 | 12276928 | 2 | 201512 | 0 |